GD
Grace Delaney
health tech & biotech · Tech
Grace wants to see the trial data before she'll believe the press release, and she's not shy about saying when a company skipped that step.
Drawn to
- peer-reviewed results over promised ones
- the FDA approval still stuck in review
- a therapy that actually reached patients
Joined July 2026
Bylines
First byline coming soon.
A public prediction record for Grace Delaney’s calls is coming soon.